<!DOCTYPE html>
<html class="no-js" lang="en"  dir="ltr">
<head>
    <title>NASA SBIR 2019-II Solicitation |  H8.01-3699
        -  Implementation of a Layer-by-Layer Manufacturing Apparatus for the Assembly of Protein-Based Retinal Implants in Low Earth Orbit | Proposal Summary </title>
    <meta charset="utf-8" />
</head>

<style>
    html,body {

        font-family: 'Source Sans Pro', Sans-Serif;
        color:#333;
    }
    @page {
        margin-left: 10pt;
        margin-right: 10pt;
        margin-top: 20pt;
        margin-bottom: 20pt;
    }
    .h1 {
        font-family: 'Source Sans Pro Bold', Sans-Serif;
        font-size: 18pt;
    }
    .h2 {
        font-family: 'Source Sans Pro Bold', Sans-Serif;
        font-size: 14pt;
    }
    .h4 {
        font-family: 'Source Sans Pro Bold', Sans-Serif;
        font-size: 8pt;
    }
    .divSourceSelection {
        display: table;
        width: 100%;
    }
    .divSourceSelection span {
        color: #f00;
    }
    .divTable {
        border: 1px #999 solid;
        display: table;
        width: 100%;
        padding: 10px 15px;
        margin: 15px 0px;
        font-family: 'Source Sans Pro', sans-serif;
        font-weight: 500;
        font-size: 18px;
    }
    .divTableRow {
        display: table-row;
    }
    .divTableRow .divTableCell .qtnLabel {
        font-weight: 600;
    }
    .divTableRow .divTableCell p {
        padding-top: 12px;
    }
    .divTableRow .qtnLabel {
        width: 85%;
        font-weight: 500;
        font-size: 14px;
    }
    .divTableRow .investorQtnLabel {
        width: 45%;
        font-weight: 500;
        font-size: 14px;
    }
    .divTableRow .odc-qtnLabel {
        font-size: 14px;
        width: 30%;
    }
    .divTableRow .odc-qtnAnswer {
        color: #3a3a3a;
        width: 31%;
        font-weight: 600;
        font-size: 14px;
    }
    .divTableCell {
        border: none;
        display: table-cell;
        padding: 12px 0px;
        font-size: 14px;
    }
    .divTableHead {
        text-align: center;
        border: none;
        display: table-cell;
        color: #3a3a3a;
        font-weight: 600;
    }
    .divTableBody {
        display: table-row-group;
    }
    .footerMsg {
        font-size: 10pt;
    }
    .qtnLabel {
        font-size: 14px;
        font-family: 'Source Sans Pro', Sans-Serif;
        font-weight: 500;
    }
    .qtnAnswer,  .col-20 {
        font-size: 14px;
        font-weight: 600;
        font-family: 'Source Sans Pro', Sans-Serif;
    }
    .solicitationDiv {
        text-align: right;
        float: right;
    }
    .headerDiv {
        text-align: center;
        padding-top: 10pt;
        padding-bottom: 5pt;
    }
    .header-title {
        margin: 0px;
        margin-top: 15px;
        background-color: #efefef;
        border: 1px solid #b6b6b6;
        padding: 9px;
        font-size: 15px;
    }
    .table-wrapper {
        width: 100%;
        display: inline-block;
        border-top: 0px;
    }
    .table-wrapper .table-row {
        border-bottom: 1px solid #b6b6b6;
        /* display: inline; */
        height: 15px;
        padding: 12px 20px;
    }
    .table-wrapper .table-row .cell-left {
        float: left;
        width: 30%;
        font-size: 14px;
    }
    .table-wrapper .table-row .cell-right {
        float: right;
        width: 70%;
        font-size: 14px;
        color: #5f5b58;
        font-weight: 600;
    }
    .table-wrapper .table-row:last-child {
        border-bottom: 0px;
    }
    .table-wrapper _table {
        width: 100%;
        border: 1px solid #b6b6b6;
    }
    .table-wrapper _table th_header {
        padding: 12px 9px;
        text-align: center;
        color: #999;
        font-weight: 600;
    }
    .table-wrapper _table th_header_title {
        text-align: center;
        padding: 5px 0px;
        color: #999;
    }
    .table-wrapper _table td_data {
        padding: 12px 9px;
        text-align: center;
        color: #484848;
        font-weight: 600;
    }
    .col-85{
        width:85%;
    }
    .col-30{
        width:30%;
        float:left;
    }

    .col-50 {
        width: 50%;
        float: left;
    }
    .col-70{
        width: 60%;
        float:left;
    }
    .col-20{
        width: 20%;
    }
    .col-15{
        width: 15%;
    }
    .totalCost{
        border: 1px solid #b6b6b6;
        padding: 4px 8px;
        width: 400px;
    }
    .summary-qtnLabel{
        width: 50%;
    }
    td.review_data {
        font-weight: 200;
    }
    .investorQtnLabel {
        width: 30%
    }
</style>

<body>
<div class="divSourceSelection">
    <div class="divTableBody">
        <div class="divTableRow">
            <div class="divTableHead">
            </div>
        </div>
    </div>
</div>
<div class="solicitationDiv"><h4>NASA SBIR 2019-II Solicitation</h4></div>
<div class="headerDiv"><h2>Proposal Summary</h2></div>
<HR noShade SIZE="3">
<div class="divTable">
    <div class="divTableBody">
            <div class="divTableRow">
                <div class="divTableCell col-20"><strong>PROPOSAL NUMBER:</strong></div>
                <div class="divTableCell">&nbsp;19-2-&nbsp;<strong>H8.01-3699</strong></div>
            </div>
            <div class="divTableRow">
                <div class="divTableCell col-20"><strong>PHASE 1 CONTRACT NUMBER:</strong></div>
                <div class="divTableCell">&nbsp;80NSSC19C0471</div>
            </div>
        <div class="divTableRow">
            <div class="divTableCell col-20"><strong>SUBTOPIC TITLE:</strong></div>
            <div class="divTableCell">&nbsp;Low Earth Orbit Platform Utilization and Microgravity Research</div>
        </div>
        <div class="divTableRow">
            <div class="divTableCell col-20"><strong>PROPOSAL TITLE:</strong></div>
            <div class="divTableCell">&nbsp;Implementation of a Layer-by-Layer Manufacturing Apparatus for the Assembly of Protein-Based Retinal Implants in Low Earth Orbit</div>
        </div>
    </div>
</div>



<B>SMALL BUSINESS CONCERN</B> (Firm Name, Mail Address, City/State/Zip, Phone)<BR>
        LambdaVision, Inc. <BR>
        400 Farmington Avenue <BR>
        Farmington, CT 06032 <BR>
        (860) 679-2558
<br><br>

<B>PRINCIPAL INVESTIGATOR</B> (Name, E-mail, Mail Address, City/State/Zip, Phone)<BR>
        
        Nicole Wagner
         <BR>
        nicole.wagner@lambdavision.com <BR>
            400 Farmington Avenue <BR>
            Farmington, CT 06032,
             CT 
            06032
             - 1913<BR>
        (774) 280-0525 <BR><BR>

    <B>BUSINESS OFFICIAL</B> (Name, E-mail, Mail Address, City/State/Zip, Phone)<BR>
        Dr.
        Jordan Greco
         <BR>
        jordan.greco@lambdavision.com <BR>
            400 Farmington Avenue <BR>
            Farmington, CT 06032,
             CT 
            06032
             - 1913<BR>
        (860) 690-5713 <BR><BR>



<div class="divTable">
    <div class="divTableBody">
        <div class="divTableRow">
            <div class="divTableCell">
                <span class="qtnLabel"><strong>Estimated Technology Readiness Level (TRL) : </strong></span>
                <br>Begin:
                4
                <br>End:
                6
            </div>
        </div>
        <div class="divTableRow">
            <div class="divTableCell">
                <span class="qtnLabel"><strong>Technical Abstract</strong></span> (Limit 2000 characters,
                approximately
                200 words)
                <BR>
                <p style="text-align:justify; margin:0in 0in 0.0001pt">LambdaVision has developed a protein-based retinal implant to restore vision to the millions of people blinded by retinal degenerative diseases, including retinitis pigmentosa and age-related macular degeneration. Preclinical evaluation of the technology demonstrated the ability to reproducibly stimulate degenerated retinal tissue and safely insert the implant into the subretinal space of both rats and pigs. The implants are manufactured using a layer-by-layer (LBL) assembly technique, in which alternating layers of the light-activated protein, bacteriorhodopsin, and a polycation are sequentially deposited onto a film. However, the current terrestrial LBL approach is influenced by gravity, in which sedimentation and gradients of solutions interfere with the quality of the implants. We hypothesize that manufacturing in a microgravity environment will improve the quality of the films and, as a result, will enhance stability and performance for future preclinical and clinical trials. A pilot manufacturing trial was carried out on the ISS via SpaceX CRS-16, which resulted in the proof of concept of creating multilayered thin films using a LEO platform. Subsequently, a Phase I SBIR effort allowed us to perform a series of parameterization experiments for follow-on spaceflight optimization. In this Phase II proposal, we will build on the terrestrial-based findings to achieve the following: (1) the completion of a LBL prototype with optimized parameters for implementation in microgravity, (2) the design of a chamber configuration that supports scale up for nonclinical non-GLP toxicity studies in a large animal model, and (3) a proof of concept of utilizing the LBL microgravity device for additional applications beyond the proposed use in vision restoration. This Phase II effort fits in to NASA&rsquo;s strategic plan for commercialization in LEO to build a sustainable production pipeline for this technology and for forthcoming technologies in the biomedical sector.</p>

            </div>
        </div>
        <div class="divTableRow">
            <div class="divTableCell">
                <span class="qtnLabel"><strong>Potential NASA Applications</strong></span> (Limit 1500
                characters, approximately 150 words)
                <BR>
                <p style="text-align:justify; margin:0in 0in 0.0001pt">This Phase II SBIR establishes the capabilities required to support LEO commercialization of protein-based retinal implants. The implant targets patients with retinal degeneration, a leading cause of blindness for millions around the globe, including astronauts exposed to extended-duration spaceflight. The work outlined will support a new sector in the Space economy, which utilizes the impact of microgravity on physical systems to improve current production methods for patient therapies.&nbsp;</p>

            </div>
        </div>
        <div class="divTableRow">
            <div class="divTableCell">
                <span class="qtnLabel"><strong>Potential Non-NASA Applications</strong></span> (Limit 1500
                characters, approximately 150 words)
                <BR>
                <p style="text-align:justify; margin:0in 0in 0.0001pt"><span style="text-autospace:none">An enhanced layer-by-layer manufacturing process can improve the homogeneity, orientation, and stability of multilayered thin films for broad applications, including retinal implants, photovoltaic cells, chemical sensors, drug delivery systems, and tissue engineering. Efficient ordering of biomaterials is of interest to scientists with technologies across therapeutic and biomedical sectors.</span></p>

            </div>
        </div>
        <div class="divTableRow">
            <div class="divTableCell">
                <span class="qtnLabel"><strong>Duration:</strong></span>
                24
            </div>
        </div>
    </div>
</div>


<HR noShade SIZE="3">
<span class="footerMsg">Form Generated on 05/04/2020 06:31:12</span>

</BODY>
</HTML>
